One year of qualification
Audited Supplier
In This Store
2-(2-(((Benzyloxy)carbonyl)amino)thiazol-4-yl)-5-((3-methylbut-2-en-1-yl)oxy)-5-oxopent-2-enoic acid
![(6R,7R)-7-Amino-3-[(Z)-2-(4-methylthiazol-5-yl]ethenyl-8-oxo-5-thia-1-azabicylo[4.2.0]oct-2-ene-2-ca](https://eimg.pharmasources.com/image/20220721/FcViPkzwzs5Z4fP741FGvuxKekYFseftohIetIkq.jpeg!200)
(6R,7R)-7-Amino-3-[(Z)-2-(4-methylthiazol-5-yl]ethenyl-8-oxo-5-thia-1-azabicylo[4.2.0]oct-2-ene-2-ca
![[6R-[6alpha,7beta(Z)]]-3-[[(Aminocarbonyl)oxy]methyl]-7-[[2-[2-[[(1,1-dimethylethoxy)carbonyl]amino]](https://eimg.pharmasources.com/image/20220721/1wJIdMeEPfOo5hfXfSgUYa4MOmIa1tsAiJrPD0Lq.jpeg!200)
[6R-[6alpha,7beta(Z)]]-3-[[(Aminocarbonyl)oxy]methyl]-7-[[2-[2-[[(1,1-dimethylethoxy)carbonyl]amino]
![(6R,7R)-Benzhydryl 3-hydroxy-8-oxo-7-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carbo](https://eimg.pharmasources.com/image/20220721/d4pDWnOv3cFW5exprvqP54TuJTGRzP1G7qWAKKqH.jpeg!200)
(6R,7R)-Benzhydryl 3-hydroxy-8-oxo-7-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carbo
7-(2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyloxy)-2,3-dihydro-4',5,7-trihydroxyflavo
![(6R,7R)-7-Amino-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid](https://eimg.pharmasources.com/image/20220720/qaJcDxx9DXa6weTQ0Sp4obE6cwrRg26nPQRAA23Q.jpeg!200)
Hubei widely chemical technology Co.,Ltd. is a modernized private enterprise specializing in the research, development, production and sales of plant extract, pharmaceutical raw material, pharmaceutical intermediate, fine chemical, veterinary raw material and other high-tech products. . Adopting high-efficient modernized management model, the company has established market-oriented marketing system. The marketing system closely coordinates the R&D, production, quality management and other departments, thus it can provide domestic and international clients with overall, convenient and perfect technical services. Adhering to the enterprise tenet as 'technology as guide, survive on quality', insisting on the enterprise philosophy as 'solidarity, pursue excellence, keep improving, mutual development', we sincerely wish to cooperate with colleagues at home and abroad for mutualdevelopment. At present, the company has developed products as Minocycline HCL; Tranexamic acid/1197-18-8;
Diphenhydramine HCL/147-24-0;Daptomycin/103060-53-3;
Neostigmine Methylsulfate/51-60-5 ;β-Menadione/58-27-5
Phytol /150-86-7;Doramectin/117704-25-3;
Tulathromycin/217500-96-4;
Gamithromycin/145435-72-9;Hygromycin B/31282-04-9;
Chloramphenicol and other products, which have met with great favor and have favorable market prospect!
Year of Establishment: 2012
Total Assets(USD): 500,000 to 99,999,999
Total Number of Staff: 100-500
Main Competitive Advantages: International Approvals/Standards,Delivery Term,Production Capacity,Buyers' Specifications Accepted
Other Competitive Advantages: In stock; the company has developed products as Minocycline HCL/13614-98-7; Tranexamic acid/1197-18-8; Diphenhydramine HCL/147-24-0 ; Daptomycin/103060-53-3; Neostigmine Methylsulfate/51-60-5 ; β-Menadione/58-27-5 Phytol /150-86-7;Doramectin/117704-25-3; Tulathromycin/217500-96-4; Fipronil/120068-37-3; Gamithromycin/145435-72-9 ; Hygromycin B/31282-04-9;
Patents and Copyrights:
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight JANUARY 2024
![D(-)-α-[(4-Ethyl-2,3-dioxopiperazinyl)carbonylamino]-2-(4-hydroxyphenyl) acetic acid](https://eimg.pharmasources.com/image/20220805/0Yi16r4o7a2NKIDqXAW1XccSIfEFzNfZnPOgeJW5.jpeg!200)
![7-AMino-3-[(5-Methyl-1,3,4-thiadiazol-2-ylthio)Methyl]-3-cepheM-4-carboxylic Acid CAS:30246-33-4](https://eimg.pharmasources.com/image/20220721/ulKfJqqWk5g4TXKw1Zh8EWJ90sY5bhnONea8K33D.jpeg!200)
![4-([1,1'-Biphenyl]-4-yl)-4-oxobutanoic acid](https://eimg.pharmasources.com/image/20220817/oo3nqeaVyQVHEV1eFq9TOW6PJKI6bG2TuTMPOE8p.jpeg!200)
![3,3',5,5'-Tetramethyl-[1,1'-biphenyl]-4,4'-diamine](https://eimg.pharmasources.com/image/20220808/R8SCh3VZ59zB78I6i1j2a83qJJjDkGwhUUWbkE8B.jpeg!200)
![(6R,7R)-3-(Acetoxymethyl)-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-](https://eimg.pharmasources.com/image/20220803/JJIoq36pu9NM3jDqW90pvgFApBYuqzrSBtihCc2r.jpeg!200)
![(Z)-2-Amino-alpha-[1-(tert-butoxycarbonyl)]-1-methylethoxyimino-4-thiazolacetic acid](https://eimg.pharmasources.com/image/20220804/i8jb6SW23WplXTcqyLRhNMtneY9RbPxjPgppXrmH.jpeg!200)
![(6R,7R)-7-Amino-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid](https://eimg.pharmasources.com/image/20220720/RTSTfxYBoLxl2zsW1gBtA9mrAcI62GZdFQy16ws2.jpeg!200)
![3-O-de[2-(acetylmethylamino)-1-oxopropyl]-Maytansine](https://eimg.pharmasources.com/image/20220720/nr3K2Gf7fKhi0rUduYf8i34xlxx1Wdd2iQpjamgQ.jpeg!200)
